Search
for
Sort by
Research 211–240 of 480
- Adalimumab-related alopecia in a patient affected by psoriasis
- Adalimumab‐induced scalp psoriasis with severe alopecia
- Drug-induced skin reactions: a pathologist viewpoint
- Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support
- Disorders of hair growth and the pilosebaceous unit: Facts and controversies
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus
- Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- ZNF750 safeguards upper hair follicle homeostasis to prevent inflammatory skin disease
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- 176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
- 305 Overlaps between inflammatory dermatoses and ichthyoses: need for novel therapeutic approaches
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Scalp Psoriasis
- Diagnosis by Hair Sample:A Rare Case of Netherton Syndrome in a 2-Year-Old Girl
- In This Issue
- [Zinc deficiency dermatoses. Etiology, clinical aspects and treatment].
- A case of dupilumab-induced psoriatic alopecia
- Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease
- P368 Rare skin disorders in IBD patients treated with anti-TNFs
- S3909 Paradoxical Psoriasis and Alopecia Areata After the Use of Anti-TNF in a Patient With Crohn's Cisease
- Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis
- Development of squamous cell carcinoma from erythroplasia of Queyrat following photodynamic therapy
- Cutaneous manifestations of systemic lupus erythematosus
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Adverse cutaneous effects of psychotropic medications